Overview

Surgery for ovarian cancer, particularly the innovative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Hyperthermic Intrathoracic Chemotherapy (HITHOC), represents a groundbreaking approach. After debulking tumor masses, heated chemotherapy is directly circulated into the abdominal or thoracic cavities, targeting residual cancer cells. HIPEC ensures maximal drug absorption, enhancing treatment efficacy. This procedure is reserved for advanced cases, preventing cancer recurrence and improving survival rates. The technique minimizes systemic side effects while maximizing the concentration of chemotherapy at the tumor site. Although demanding, HIPEC/HITHOC showcases promising results, transforming ovarian cancer management and offering new hope in the quest for more effective treatments. Advances in surgical techniques continually refine this approach for enhanced outcomes.